Tuesday, May 7, 2024 – We at Jett Foundation are deeply saddened to learn about the devastating loss of a child participating in Pfizer’s Phase 2 DAYLIGHT clinical trial for Duchenne muscular dystrophy. Our hearts go out to the child’s family during this incredibly difficult time.
Please see Pfizer’s Community Letter to read more. We will continue to share any additional updates through our Duchenne News blog as the company investigates this matter.
